Predictors of Conduction Disturbances Requiring a Late Permanent Pacemaker

This analysis shows that baseline right bundle branch block and increased PR length after transcatheter aortic valve replacement (TAVR) are independent predictors of advanced conduction disturbances requiring late pacemaker implantation. A simple electrocardiography can detect these potentially fatal conduction disturbances that might happen more than 48 hours after TAVR.

Data from consecutive TAVR patients from one center (Milan, Italy) were gathered between 2007 and 2015. Delta PR and delta QRS were defined as the difference between the last PR and QRS length available 48 hrs. after TAVR and baseline PR and QRS length.

 

The study looked at data from 740 patients, excluding 78 that already had a pacemaker and 51 that had received one less than 48 hrs. after TAVR, which left 611 patients for final analysis.

 

8.8% developed conduction disturbances requiring a pacemaker ≥48h after procedure. Patients requiring late pacemaker implantation had wider QRS (113 ± 25 ms vs. 105 ± 23 ms; p=0.009), higher prevalence of right bundle branch block (12.9% vs. 5.3%; p=0.026) and were more likely to receive a self-expandable valve (51.8% vs. 31.9%; p=0.003).


Read also: EXCEL Sub-Analysis: Angioplasty vs. Surgery in Chronic Renal Insufficiency.


Delta PR was 40 ± 51 ms (p=0.0001) and delta QRS was 22 ± 61 ms (p=0.001).

 

Multivariable analysis showed that baseline right bundle branch block had between 3.5 and 4 times higher risk of getting a pacemaker (p=0.0001) and delta PR increased this risk by 1.3 times every 10 ms (p=0.0001).

 

Conclusion

The evidence consolidates in favor of a simple ECG to detect patients at higher risk of requiring late pacemaker implantation after TAVR. Baseline bundle branch block and increased PR are predictors of late advanced conduction disturbances.

 

Original title: Predictors of Advanced Conduction Disturbances Requiring a Late (≥48 hs) Permanent Pacemaker Following Transcatheter Aortic Valve Replacement.

Reference: Antonio Mangieri et al. J Am Coll Cardiol Intv 2018;11:1519–26.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

Prospective Analysis of the Feasibility of the PASCAL System for Transcatheter Mitral Repair: OneForAll Registry

Courtesy of Dr. Juan Manuel Pérez. Mitral transcatheter edge-to-edge repair (M-TEER) is an effective option for patients with severe mitral regurgitation who are at high...

Left Bundle Branch Block after TAVR: What Is Its Impact?

Courtesy of Dr. Juan Manuel Pérez. Left bundle branch block (LBBB) is a common complication following transcatheter aortic valve replacement (TAVR), which can be either...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC 2025 | BHF PROTECT-TAVI: Are Cerebral Protection Systems Necessary in TAVI?

TAVI has seen a steady increase in use, though stroke continues to be one of its unwanted complications, mostly ischemic and, less frequently, hemorrhagic. The...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...